2026 AGENDA

Boston, 29 - 30 September 2026

Schedule

• Sep 29
• Sep 30

Filter your schedule:

Topics:

Keynote Session Roundtables FAIR Data: Management, Storage and Architecture AI in Clinical Trials Real World Evidence Large Language Models Digital Transformation AI in Drug Discovery and Development Startup Pitches Bioinformatics + InSilico R&D Clinical Technology & Innovation

Start time filter:

Morning (8-11.30) Midday (11.30-2.30) Afternoon (2.30-6.30)

Favourites:

Favourites only

Retrieve Save

Clear filters

Create your personal agenda –check the favourite icon

Sep 298:50

Conference pass

Introductory remarks

Keynotes

Anna Abiola, Conference Director, Terrapinn Holdings Ltd

Sep 298:55

Conference pass

Chair's remarks

Keynotes

Emily Gillen, Head of Global Data Partnerships, UCB

Sep 299:00

Conference pass

Advancing the development of individualised genetic therapies

Keynotes

Peter Marks, SVP Molecule Discovery and Head of Infectious Diseases, Eli Lilly

Sep 299:20

Conference pass

Investment trends in AI

Keynotes

Moderator: Rana Lonnen, General Partner, Science Capital Ventures

Issa Kildani, Managing Partner, Founder, Ambrosia Ventures

Pooja Majmudar, Investment Partner, KELES Digital Health

Divya Yerraguntla, Angel Investor, Life Science Angels

Sarah Johnson, Partner, Advantary Capital Partners

Sep 2910:40

Conference pass

Roundtables

Roundtables

Agentic AI in Drug Discovery

Stephanie Oestreich, Managing Director, Myeloma Investment Fund

AI-Driven Futures: Roadmap to Digital Transformation

Shabana Motlani, Director, USO PS QA & GxP Automation & Analytics, Novo Nordisk

AI‑Ready Drug Discovery: What It Actually Takes

Kausheek Nandy, Digital Transformation Director – Research, Boehringer Ingelheim

Best ways to structure pre clinical data to de risk technologies before clinical trials

Kristin Falkenstein, Assistant Director of Business Development, University of Texas at Austin- Discovery to Impact

Building the Intelligent Health Ecosystem: Where Pharma Meets AI Powered by Real-World Data

Kalindi Bakshi, Division Head- Life Science & Food Innovation, Middlesex County New Jersey

From Complexity to Clarity: Single-Cell, Spatial, and Multi-Omics

Isha Parikh, Bioinformatician, Dana Farber Cancer Institute

Integrating automation and AI into product development

Danyel Evseev, Process Development Lead, Riddell Centre for Cancer Immunotherapy, University of Calgary

Investment Trends in 2026: AI is everywhere, where Capital Is Actually Going (and Why)? Real investor perspectives + live founder feedback

Vivian Li, Early Stage Investor, K2VC

Sep 2911:40

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Sree Chitoor, Chief Technology Officer, IAVI

Sep 2911:40

Conference pass

Chair's remarks

AI in Clinical Trials

J.P. Li, Co-Chairman / Board Director, Meridian Universal Health Group Inc. / Wharton Alumni Angels

Sep 2911:40

Conference pass

Chair's remarks

Real World Evidence

Catherine Brownstein, Assistant Professor, Harvard Medical School

Sep 2911:40

Conference pass

Chair's remarks

Large Language Models

Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic

Sep 2911:40

Conference pass

Chair's remarks

Digital Transformation

Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc

Sep 2911:40

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Christopher Bishop, Chief Reinvention Officer, Improvising Careers

Sep 2911:45

Conference pass

AI-Driven Endpoints: Redefining Clinical Trials for the Next Decade

AI in Clinical Trials

Agata Krason, Medical Imaging Data Scientist, Roche

Sep 2911:45

Conference pass

AI-ready data, foundation models, and agents for clinical trial optimization

AI in Drug Discovery and Development

Etai Jacob, Head of Data Science and AI, Oncology R&D, AstraZeneca

Sep 2911:45

Conference pass

Digital Transformation Is Not a Line, It's a Circle

Digital Transformation

Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc

Sep 2911:45

Conference pass

Engineering Certainty and Clinical Safety: From Probabilistic to Deterministic AI

Large Language Models

Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic

Sep 2911:45

Conference pass

Integration of real world evidence in genomics discovery

Real World Evidence

Catherine Brownstein, Assistant Professor, Harvard Medical School

Sep 2911:45

Conference pass

Safety Data Management & AI Automation

FAIR Data: Management, Storage and Architecture

Vikalp Khare, Director, US Head of Safety Data Management, Otsuka Pharmaceutical

Sep 2912:05

Conference pass

From insights to evidence: AI-enabled real-world intelligence for GLP-1 research

Real World Evidence

Spencer Andrei, PhD, Life Science Director, Truveta

Sep 2912:05

Conference pass

Generative AI for the Lab: Streamlining Scientific Workflows Through Intelligent Integration

AI in Clinical Trials

Akhil Rachamadugu, Director, Life Sciences, ServiceNow

Sep 2912:05

Conference pass

In Silico-Enabled Biologics: Transforming Molecular Biology Design Through Integrated Informatics

Digital Transformation

Veronica DeFelice, Director of Biologics, Sapio Sciences

Sep 2912:05

Conference pass

RenSuper Workstation: An AI-Driven Antibody Discovery Platform From Target to Antibody Leads in Click

AI in Drug Discovery and Development

Icy Niu, Executive Director of BD & Marketing, Biocytogen

Sep 2912:25

Conference pass

Accelerating trial selection with AI agents

Real World Evidence

Irfan Shah, Digital Ventures, Memorial Sloan Kettering Cancer Center

Sep 2912:25

Conference pass

AI-driven trial design and optimization

AI in Clinical Trials

J.P. Li, Co-Chairman / Board Director, Meridian Universal Health Group Inc. / Wharton Alumni Angels

Sep 2912:25

Conference pass

AI-powered programmable virtual humans for physiologically based drug discovery

AI in Drug Discovery and Development

Lei Xie, Professor, Northeastern University

Sep 2912:25

Conference pass

Implementation of new age AI solutions and how to keep up with them

Digital Transformation

Anubhav Srivastava, Associate Director, Novo Nordisk Inc.

Sep 2912:25

Conference pass

Multimodal Multi-Agent Solution for Sales Representatives

Large Language Models

Shihan He, Machine Learning Engineer, Novo Nordisk Inc.

Sep 2912:25

Conference pass

The Data Dilemma: Storage, Management, and the Privacy Puzzle

FAIR Data: Management, Storage and Architecture

Joel Schwarz, Adjunct Law Professor, Cybersecurity and Privacy, Albany Law School

Sep 2912:45

Conference pass

AI Built for Research: Accelerating Defensible Evidence from Real-World Data

Real World Evidence

Most AI isn't built for research. It's built for chat, for dashboards, for demos. In HEOR, that gap shows up fast. Fragmented data. Opaque models. Manual workflows that break the moment a regulator or peer reviewer asks how an answer was produced.

This session outlines a different approach: healthcare-native AI designed specifically for rigorous, defensible evidence. Three pieces, working together. A Healthcare Map of 60+ curated sources with validated representativeness across payers, regions, and care settings. A research-specific architecture with unified visit consolidation, 95%+ cost fill, and continuous enrollment, built so methodology holds up under scrutiny. And an AI engine with visible code generation, stepwise validation, and explicit articulation of every limitation.

The result is RWE that's faster, scalable, and trusted. Cohort identification compressed from hours to minutes. Descriptive statistics that used to take months. Industry standard R-package integration for inferential methods like propensity score matching, survival modeling, and weighted analyses, all version-controlled and replicable. Ready for the moments that matter most: market access discussions, internal strategic decision making, peer reviewed publications, and guideline directed medical therapy for real patients.

Key Learning Objectives

By the end of this session, attendees will be able to:

• Recognize why most AI approaches fail to meet the standards of HEOR research, including issues of data quality, transparency, and scientific rigor.
• Understand the three integrated components of healthcare-native AI: a comprehensive data foundation, a research-specific architecture, and an AI engine built for auditability.
• Map each safeguard to its purpose: visible code for auditable methods, cost imputation for unbiased economics, representativeness for generalizability.
• Identify HEOR use cases (feasibility, cohort construction, treatment patterns, cost and outcomes analyses) where AI built for research can compress timelines from months to minutes while preserving scientific integrity.

Hannah Barman, Principal Product Strategy Manager, Komodo Health

Sep 2912:45

Conference pass

Digital Transformation in Pharma Is Missing a Layer: Validation, Trust, and Submission Readiness

Digital Transformation

Ilan Carmeli, Coo & Co-founder, Beaconcure

Sep 2912:45

Conference pass

Sponsored presentation

FAIR Data: Management, Storage and Architecture

Deepak Rajendran, Senior Manager, Zifo Technologies Inc

Sep 2913:05

Conference pass

A data science ecosystem for pharma R&D

FAIR Data: Management, Storage and Architecture

Daniel Gusenleitner, Mission Lead of the Pharma R&R Data Science Ecosystem, Bayer

Sep 2913:05

Conference pass

A data science ecosystem for pharma R&D

FAIR Data: Management, Storage and Architecture

Daniel Gusenleitner, Mission Lead of the Pharma R&R Data Science Ecosystem, Bayer

Sep 2913:05

Conference pass

Digital transformation in biotherapeutics discovery

Digital Transformation

Alexander Horspool, Associate Director of Data and Lab Automation, Boehringer Ingelheim

Sep 2913:05

Conference pass

DNA Methylation-Mediated Epigenetic Adaptation Promotes Cellular Resilience In AML

Real World Evidence

Manna Ahmed, Assistant Research Professor - Manager of The Genomics Resource Facility, Fox Chase Cancer Center

Sep 2913:05

Conference pass

Navigating launch challenges in rare disease markets

AI in Drug Discovery and Development

Soumavo Sarkar, Director, Novartis

Sep 2913:05

Conference pass

Physics-Informed Large Language Models for Biologics: Applying Nuclear Engineering Rigor to AI Safety and Reliability

Large Language Models

Daya Shankar, Dean, School of Sciences and Founder SuktiAI, Woxsen University

Sep 2913:05

Conference pass

Virtual patient generation leveraging RWD to expedite clinical development

AI in Clinical Trials

Yilin Xu, Head of clinical data analytics, AbbVie

Sep 2913:25

Conference pass

The Agent Did It. Now Can You Prove It? Cryptographic Traceability for AI in Clinical Workflows

Startup Pitches

Alistair Dootson, Head Life Sciences, EQTY Life Sciences

Tina Morrison, Head of Life Sciences, EQTY Lab

Sep 2913:40

Conference pass

Responsible AI by Design: How to Launch Agentic AI in Regulated Biotech

Startup Pitches

Atika Kumar, Founder, Wiztree Consulting

Sep 2913:55

Conference pass

AI-Driven Insights from Every single Patient

Startup Pitches

Mattia Marco Caruson, Managing Director, mama health

Sep 2914:10

Conference pass

Using Multi-Modal patient data for Reinforcement Learning and Digital Twins for Biology Workflows

Startup Pitches

Sumit Sinha, Founder & CEO, OmicsBank

Sep 2914:25

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Christopher Bishop, Chief Reinvention Officer, Improvising Careers

Sep 2914:25

Conference pass

Chair's remarks

Large Language Models

Saeed Amal, Research Professor In AI for Precision Medicine at Northeastern University and Visiting Professor at Harvard Medical School, Northeastern University

Sep 2914:25

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Lori Hoepner, Asst Professor, SUNY DOWNSTATE

Sep 2914:25

Conference pass

Chair's remarks

AI in Clinical Trials

Soumavo Sarkar, Director, Novartis

Sep 2914:25

Conference pass

Chair's remarks

AI in Clinical Trials

Soumavo Sarkar, Director, Novartis

Sep 2914:25

Conference pass

Chair's remarks

Real World Evidence

Michael Liebman, Managing Director, IPQ Analytics, LLC

Sep 2914:30

Conference pass

AI based first draft document authoring in support of clinical trials

AI in Drug Discovery and Development

Chris Willis, Director, Research Business Insights & Technology, Bristol Myers Squibb

Sep 2914:30

Conference pass

Development Assistant: Empowering AZ with Interoperable, Context‑Driven Insights

AI in Clinical Trials

Betsy luo, IT Business Analyst, AstraZeneca

Sep 2914:30

Conference pass

Digital Transformation in Biomedical Research: Challenges and Opportunities

Digital Transformation

Jason Beckwith, Professor, University of Dundee

Sep 2914:30

Conference pass

Large Language Models in Practice: From Patient Support to Precision Cancer Care

Large Language Models

Omer Alis, Director of Artificial Intelligence, Northeastern University

Sep 2914:30

Conference pass

Multi-cancer Early Detection (MCED)

Real World Evidence

Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center

Sep 2914:30

Conference pass

Pitfalls and Best Practices: Notes from the (research) field

FAIR Data: Management, Storage and Architecture

Lori Hoepner, Asst Professor, SUNY DOWNSTATE

Sep 2914:50

Conference pass

Untangling the RWD Knot: An LLM Workflow for Assessing IBD Clinical Notes To Characterize Treatment Response

AI in Drug Discovery and Development

Leeland Ekstrom, CEO & Co-Founder, NashBio

Sep 2915:10

Conference pass

Agentic AI for biotech competitive intelligence

Large Language Models

Daniel de Moraes Branco, Senior Director Corporate Development, Latin America Medical Affairs Lead, Medicinia

Sep 2915:10

Conference pass

AI in Drug Development and Discovery - an investors perspective

AI in Drug Discovery and Development

Colby Kash, Ceo, Camelot BioCapital

Sep 2915:10

Conference pass

Digital innovations driving clinic trials efficiencies

AI in Clinical Trials

Naomi Fried, CEO, Pharmstars

Sep 2915:10

Conference pass

From Data Custodian to Data Product Leader: Building FAIR and AI-Ready Clinical Data Platforms for Precision Trials

FAIR Data: Management, Storage and Architecture

Kayure Patel, Senior Data Sciences Product Leader, Genentech/Roche

Sep 2915:10

Conference pass

HEART: Healthcare Enabled by AI in Real Time

Real World Evidence

Qingchu Jin, Research Scientist, Northeastern University

Sep 2915:10

Conference pass

Securing the Agentic Future: How Privacy and Trust Drive Real Digital Transformation

Digital Transformation

Preetha Ram, Managing Partner, Pier 70 Ventures

Sep 2915:30

Conference pass

The Skills Behind the Strategy: Preparing Today's Workforce for Digital Transformation

Digital Transformation

Uwe Hohgrawe, Associate Dean Global Learner Access, Strategic Partnerships and AI, Northeastern University

Sep 2915:50

Conference pass

AI ML for drug discovery

AI in Drug Discovery and Development

Srijit Seal, Visiting Researcher, Broad Institute of MIT and Harvard

Sep 2915:50

Conference pass

Applications of biological foundation models to accelerate clinical trials

AI in Clinical Trials

Neil Pfister, Assistant Professor; Head of AI in Precision Medicine Research Group, University of Alabama at Birmingham

Sep 2915:50

Conference pass

Digital transformation within medical and scientific communications within pharma and biotech

Digital Transformation

Michelle Bridenbaker, Head of Medical Excellence & Communications, Recordati

Sep 2915:50

Conference pass

Diving deeper into indications

FAIR Data: Management, Storage and Architecture

Maureen Stark, Biospecimen Senior Specialist - Data Mgt, Roche

Sep 2915:50

Conference pass

Medical information response agent

Large Language Models

Chandni Patel, Director, Medical Information, Novo Nordisk

Sep 2915:50

Conference pass

The Human Heart of High-Tech Care: Reimagining the Nurse Navigator in the Age of Precision Medicine

Real World Evidence

the field of oncology continues to explorecutting-edge breakthroughs in AI, genomic sequencing, and digital transformation, it’s easy to lose sight of the human being at the center—the patient. While industry leaders focus on the data and the drug, the Oncology Nurse Navigator (ONN) never loses sight of the person behind the diagnosis. This presentation brings the ONN’s story to life as the “human translator” of biotechnology—turning intimidating data into understandable choices, calming fears, and ensuring that the promise of precision medicine is matched by genuine, personalized support.

Objectives:By the end of this presentation, participants will be able to:

• Identify the three primary psychological and logistical barriers patients face when transitioning from standard care to high-complexity interventions.

• Analyze how the navigator role mitigates disparities in access to precision medicine by addressing social determinants of health (SDOH) that digital platforms often overlook.

• Formulate a model for integrating biotech stakeholders (pharma, diagnostics, and tech) with the nursing navigation team to ensure innovations enhance, rather than disrupt, the patient experience

Jackie Miller, Director Oncology Navigation, SKCCC-Jefferson Health

Sep 2916:40

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Pooja Majmudar, Investment Partner, KELES Digital Health

Sep 2916:40

Conference pass

Chair's remarks

Large Language Models

Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham

Sep 2916:40

Conference pass

Chair's remarks

Digital Transformation

Shabana Motlani, Director, USO PS QA & GxP Automation & Analytics, Novo Nordisk

Sep 2916:40

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Harish Manmathan, Sr. Director, Trial Delivery Data Strategy, Takeda

Sep 2916:40

Conference pass

Chair's remarks

AI in Clinical Trials

Jin Lee, Founder, IMIDeology

Sep 2916:40

Conference pass

Chair's remarks

Real World Evidence

Michael Liebman, Managing Director, IPQ Analytics, LLC

Sep 2916:45

Conference pass

Bridging the gap between FEMtech and FEMhealth

Real World Evidence

Michael Liebman, Managing Director, IPQ Analytics, LLC

Sep 2916:45

Conference pass

Leveraging Data and AI to transform Research, Care, and Operations at Sylvester Comprehensive Cancer Center

Digital Transformation

Vasileios Stathias, Assistant Director, Data Science, Sylvester Comprehensive Cancer Center

Sep 2916:45

Conference pass

LLMs for Medical Affairs: Content, Engagement, and Meaningful Scientific Impact for HCPs

Large Language Models

John Wright, Technology Director, Global Medical Affairs, amgen

Sep 2916:45

Conference pass

Protecting Our Cognitive Edge: The Paradox of AI Offloading vs. Skills Atrophy

AI in Clinical Trials

Lincoln Shand, Global Technical Leader, Data Management, PD Data Science and Analytics, Roche

Sep 2916:45

Conference pass

ROI on AI implantation in drug discovery

AI in Drug Discovery and Development

Pooja Majmudar, Investment Partner, KELES Digital Health

Sep 2917:05

Conference pass

Building Contextual Layer for Agentic Framework for Clinical Data Science

Large Language Models

Mukul Virmani, Director, Clinical Data Science, AI Research Center, Gilead Sciences, Inc.

Sep 2917:05

Conference pass

How Novo Nordisk Transformed Customer targeting using AI

Digital Transformation

Sai Rithvik Kanakamedala, Data Scientist, Novo Nordisk

Sep 2917:05

Conference pass

Robust AI

AI in Clinical Trials

Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk

Sep 2917:25

Conference pass

AI-Powered Trials: Unlocking Leadership in Clinical Innovation

Real World Evidence

Moderator: Angela Gill Nelms, Managing Director, Biolocity at GT and Emory

Yilin Xu, Head of clinical data analytics, AbbVie

Hong Truong, Principal, Define Ventures

Sep 2917:25

Conference pass

Better ways to recruit and retain patients

AI in Clinical Trials

Moderator: Jin Lee, Founder, IMIDeology

Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk

Shahanaz Rahman, Senior Clinical Trials Manager, ITM

Jackie Miller, Director Oncology Navigation, SKCCC-Jefferson Health

Sep 2917:25

Conference pass

Digital health and AI, what does the future hold?

Digital Transformation

Moderator: Naomi Fried, CEO, Pharmstars

Omer Alis, Director of Artificial Intelligence, Northeastern University

Saeed Amal, Research Professor In AI for Precision Medicine at Northeastern University and Visiting Professor at Harvard Medical School, Northeastern University

Sep 2917:25

Conference pass

From AI Experiments to Enterprise Impact: What Does It Really Take to Operationalize AI in Pharma

Large Language Models

Moderator: Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence, Merck

Chandni Patel, Director, Medical Information, Novo Nordisk

Othel Rolle, Senior Manager, Digital Research & Innovation, Johnson & Johnson

Sep 2917:25

Conference pass

The Health Data Trilemma: Privacy, National Security, and Borderless dataflows

FAIR Data: Management, Storage and Architecture

Moderator: Joel Schwarz, Adjunct Law Professor, Cybersecurity and Privacy, Albany Law School

Sep 2917:25

Conference pass

Using AI in the drug development and discovery process

AI in Drug Discovery and Development

Moderator: Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs, University of Washington

David Sherris, ceo, Attivare Therapeutics

Nabil Adam, Professor Emeritus/Co-founder, Rutgers University

Create your personal agenda –check the favourite icon

Sep 308:50

Conference pass

Introductory remarks

Keynotes

Anna Abiola, Conference Director, Terrapinn Holdings Ltd

Sep 308:55

Conference pass

Chair's remarks

Keynotes

Christina Waters, Chief Executive Officer, RARE Science

Sep 309:00

Conference pass

Biotech in the balance

Keynotes

Jeremy Levin, Executive Chairman, Ovid Therapeutics

Sep 309:20

Conference pass

Evolution of women’s health

Keynotes

Moderator: Michelle Bridenbaker, Head of Medical Excellence & Communications, Recordati

Preetha Ram, Managing Partner, Pier 70 Ventures

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs, University of Washington

Sep 3011:40

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Venkat Sanka, Data Analytics & Governance Consultant, Janssen Global Services LLC

Sep 3011:40

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence, Merck

Sep 3011:40

Conference pass

Chair's remarks

Bioinformatics + InSilico R&D

Qingchu Jin, Research Scientist, Northeastern University

Sep 3011:40

Conference pass

Chair's remarks

AI in Clinical Trials

Angela Gill Nelms, Managing Director, Biolocity at GT and Emory

Sep 3011:45

Conference pass

AI in medical authoring and regulatory intelligence

AI in Clinical Trials

Sree Chitoor, Chief Technology Officer, IAVI

Sep 3011:45

Conference pass

Beyond SPIRs calling NIH as your technology development and commercialisation partner

Clinical Technology & Innovation

Michael Salgaller, Supervisory Specialist, Technology Analysis and Marketing Unit (TAMU), National Institute of Health (NIH)

Michael Salgaller, Supervisory Specialist, Technology Analysis and Marketing Unit (TAMU), National Institute of Health (NIH)

Sep 3011:45

Conference pass

From High-Throughput Pipelines to FAIR Data: A Storage Strategy

FAIR Data: Management, Storage and Architecture

Venkat Sanka, Data Analytics & Governance Consultant, Janssen Global Services LLC

Sep 3011:45

Conference pass

Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

Real World Evidence

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence, Merck

Sep 3011:45

Conference pass

How AI can help early stage companies in drug development

AI in Drug Discovery and Development

Lou Kassa, CEO, Pennsylvania Biotechnology Center

Sep 3011:45

Conference pass

When Quantum Meets Pharma: Inside the Race to Design Drugs Atom by Atom

Bioinformatics + InSilico R&D

Christopher Bishop, Chief Reinvention Officer, Improvising Careers

Sep 3012:25

Conference pass

Building Bridges: Developing a Common Omics Data Platform at AbbVie

FAIR Data: Management, Storage and Architecture

Brett Engelmann, Sr Data Scientist, AbbVie

Sep 3012:25

Conference pass

Multi-modal real world data foundation models: Challenges & opportunities

AI in Drug Discovery and Development

Janie Shelton, Director, Translational Epidemiology, Bristol Myers Squibb

Sep 3012:25

Conference pass

Patient advocate journey through trials

AI in Clinical Trials

Ella Balasa, Patient Engagement Consultant, Patient Advocate

Sep 3012:25

Conference pass

The Convergence of Patient Safety and Real-World Evidence in a Data-Driven Era

Real World Evidence

Osamagbe Woghiren, Senior Manager, QPPV Office & International Pharmacovigilance Operations, UCB

Sep 3012:25

Conference pass

Virtual cell modelling

Bioinformatics + InSilico R&D

Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham

Sep 3012:45

Conference pass

AI to select biomarker candidates

AI in Drug Discovery and Development

Fernanda Cerqueira, Senior Associate Director, Michael J Fox Foundation for Parkinson's Research

Sep 3012:45

Conference pass

Leveraging Real-World Data and AI for the Evaluation of Clinical Trial Efficacy.

AI in Clinical Trials

Nabil Adam, Professor Emeritus/Co-founder, Rutgers University

Sep 3013:05

Conference pass

From Silos to FAIR: Driving Data Strategy in Research and Development

FAIR Data: Management, Storage and Architecture

Harish Manmathan, Sr. Director, Trial Delivery Data Strategy, Takeda

Sep 3013:05

Conference pass

How to integrate multi-omics

Bioinformatics + InSilico R&D

Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard

Sep 3013:05

Conference pass

Leveraging RWD in the Drug Development Process

Real World Evidence

Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk

Sep 3013:05

Conference pass

Mind the Gap: How Artificial Intelligence Can Strengthen the Clinical Trial Enterprise from Protocol Design to External Controls

AI in Clinical Trials

Alexander Sherman, Director, Center for Innovation and Bioinformatics, Mass General Hospital, Harvard Medical School

Sep 3013:05

Conference pass

Revolutionizing immunotherapy through patient-centric therapeutic hardware platform, ATT-AI

AI in Drug Discovery and Development

David Sherris, ceo, Attivare Therapeutics

Sep 3013:25

Conference pass

From Synopsis to Shortlist in Seconds: AI-Powered Site Selection & Feasibility

Startup Pitches

Dylan Wallace, Director of Business Development, Ryght, Inc.

Sep 3013:40

Conference pass

From Innovation to Revenue: Fixing the Commercial Gap in Science-Led

Startup Pitches

Strong innovation doesn’t automatically lead to commercial success. Many science-led companies struggle to translate capability into revenue. This session introduces a platform that identifies commercial gaps and turnsinnovation into a clear, execution-ready growth strategy.

Nandy Thaver, Director, Thaver Consulting

Sep 3014:25

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Michael Liebman, Managing Director, IPQ Analytics, LLC

Sep 3014:25

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Venkat Sanka, Data Analytics & Governance Consultant, Janssen Global Services LLC

Sep 3014:25

Conference pass

Chair's remarks

AI in Clinical Trials

Angela Gill Nelms, Managing Director, Biolocity at GT and Emory

Sep 3014:30

Conference pass

AI influenced nano technology in drug discovery and development

AI in Drug Discovery and Development

Beauty Pandey, Associate Dean & Associate Professor, Woxsen University

Sep 3014:30

Conference pass

Detecting Dengue, Chikungunya, and Oropouche Viruses Using Radio Frequency Waves and Machine Learning.

Bioinformatics + InSilico R&D

Omer Alis, Director of Artificial Intelligence, Northeastern University

Sep 3014:30

Conference pass

Driving field medical innovation

Real World Evidence

Karuna Kantor, Director, Field Medical, Novo Nordisk

Sep 3014:50

Conference pass

How AI is used to support the three R’s in drug discovery

AI in Drug Discovery and Development

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs, University of Washington

Sep 3015:10

Conference pass

An ensemble method for robust labelling of single-cell RNA-seq data

Bioinformatics + InSilico R&D

MaryLena Bleile, Senior Statistician, Sanofi

Sep 3015:10

Conference pass

Preparing the Biotech Workforce of the Future: The Role of Academic-Industry Partnerships

Real World Evidence

Ikhide Imumorin, Executive Director & Professor of Biological Sciences,, California State University

Sep 3015:10

Conference pass

Regulatory affairs, The regulations and guidance globally

AI in Drug Discovery and Development

Jia Huang, Associate Director, Merck

Sep 3015:50

Conference pass

Pediatric Precision Medicine

Keynotes

Wendy Chung, Chief, Department of Pediatrics, Boston Children's Hospital

last published: 18/May/26 12:35 GMT

×

Your personalised agenda

You can save your preferred agenda items for future reference. If you reset your password an new one will be sent to the email address specified below, that we have on account.

Your email address…

Your password…

CloseLoginReset password

Password must meet the following requirements:

• At least one letter
• At least one capital letter
• At least one number
• Be at least 6 characters

×

Peter Marks / Advancing the development of individualised genetic therapies

Peter Marks, SVP Molecule Discovery and Head of Infectious Diseases,
Eli Lilly

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring...

CloseMore

×

Divya Yerraguntla / Investment trends in AI

Divya Yerraguntla, Angel Investor,
Life Science Angels

An established leader and influencer in the Pharmaceutical industry, Divya has been in the industry for more than 25 years, working with companies such as Johnson & Johnson, Novo Nordisk, SUN Pharma, and Syneos Health. She is a seasoned Speaker and chairperson of various Pharmaceutical Forums...

CloseMore

×

Kausheek Nandy / Roundtables

Kausheek Nandy, Digital Transformation Director – Research,
Boehringer Ingelheim

Kausheek is a global leader with 15+ years experience in Healthcare & Technology space– steering and leading teams, products & programs. He has diverse leadership experience across multiple domains in Healthcare - data science, marketing & sales, legal & compliance, Head of IT and...

CloseMore

×

Kristin Falkenstein / Roundtables

Kristin Falkenstein, Assistant Director of Business Development,
University of Texas at Austin- Discovery to Impact

Dr. Kristin Falkenstein is the Assistant Director of Business Development with the Discovery to Impact team at The University of Texas at Austin.  In her role she strives to partner with pharmaceutical and biotechnology companies to advance early‑stage biomedical innovations from academic discovery ...

CloseMore

×

Kalindi Bakshi / Roundtables

Kalindi Bakshi, Division Head- Life Science & Food Innovation,
Middlesex County New Jersey

Kalindi Bakshi PhD is a leader in life sciences and food innovation ecosystem development, currently leading the Life Sciences and Food Innovation division at Middlesex County’s Office of Business Engagement. She works at the intersection of industry, government, and innovation, supporting domestic ...

CloseMore

×

Vivian Li / Roundtables

Vivian Li, Early Stage Investor,
K2VC

Dr. Vivian Li holds a PhD in Biomedical Sciences from The Chinese University of Hong Kong and an MBA from Johns Hopkins University, with a distinguished background bridging science and business on a global scale. She conducted postdoctoral research at the University of Pennsylvania and worked in...

CloseMore

×

J.P. Li / Chair's remarks

J.P. Li, Co-Chairman / Board Director,
Meridian Universal Health Group Inc. / Wharton Alumni Angels

Mengyue (J.P.) Li – Biography With domestic and international experience across higher education, banking, healthcare, and venture capital (VC) & private equity (PE), J.P. embarked on his first entrepreneurial journey by acquiring and scaling a local business in Houston, Texas. Under his...

CloseMore

×

Jennifer Heymont / Chair's remarks

Jennifer Heymont, Associate Director, Scientific Informatics,
Eisai Inc

Jennifer's strong foundation in math and biology naturally led to a career in data science. Beginning as a Scientific Applications Developer over 15 years ago, today she is the Associate Director of Scientific Informatics at Eisai G2D2. In this role, she focuses on processes that transform data ...

CloseMore

×

Christopher Bishop / Chair's remarks

Christopher Bishop, Chief Reinvention Officer,
Improvising Careers

Christopher Bishop is a TEDx speaker, ex-IBMer, former NYC studio cat, touring rock musician, future workplace consultant, and a firm believer in the power of bleeding-edge technologies to drive exciting and innovative careers. He is the author of the groundbreaking new book Improvising Careers:...

CloseMore

×

Agata Krason / AI-Driven Endpoints: Redefining Clinical Trials for the Next Decade

Agata Krason, Medical Imaging Data Scientist,
Roche

Agata Krason is a Clinical AI Scientist and Senior Medical Imaging Data Scientist at F. Hoffmann-La Roche Ltd, where she works at the intersection of artificial intelligence, medical imaging, and clinical data science to accelerate precision oncology. Her research focuses on building clinically...

CloseMore

×

Jennifer Heymont / Digital Transformation Is Not a Line, It's a Circle

Jennifer Heymont, Associate Director, Scientific Informatics,
Eisai Inc

Jennifer's strong foundation in math and biology naturally led to a career in data science. Beginning as a Scientific Applications Developer over 15 years ago, today she is the Associate Director of Scientific Informatics at Eisai G2D2. In this role, she focuses on processes that transform data ...

CloseMore

×

J.P. Li / AI-driven trial design and optimization

J.P. Li, Co-Chairman / Board Director,
Meridian Universal Health Group Inc. / Wharton Alumni Angels

Mengyue (J.P.) Li – Biography With domestic and international experience across higher education, banking, healthcare, and venture capital (VC) & private equity (PE), J.P. embarked on his first entrepreneurial journey by acquiring and scaling a local business in Houston, Texas. Under his...

CloseMore

×

Anubhav Srivastava / Implementation of new age AI solutions and how to keep up with them

Anubhav Srivastava, Associate Director,
Novo Nordisk Inc.

Anubhav Srivastava is an accomplished professional with over 19 years of experience in the pharmaceutical and healthcare industry. Currently serving as the Associate Director at Novo Nordisk Inc., Anubhav is a visionary leader known for driving innovation and precision in the field. With a strong...

CloseMore

×

Ilan Carmeli / Digital Transformation in Pharma Is Missing a Layer: Validation, Trust, and Submission Readiness

Ilan Carmeli, Coo & Co-founder,
Beaconcure

Ilan Carmeli is Co-founder and COO of Beaconcure, where he leads the development of AI-driven solutions for clinical trials. With deep knowledge in building user-centric software products, Ilan focuses on bridging the gap between advanced AI capabilities and the strict requirements of regulated...

CloseMore

×

Christopher Bishop / Chair's remarks

Christopher Bishop, Chief Reinvention Officer,
Improvising Careers

Christopher Bishop is a TEDx speaker, ex-IBMer, former NYC studio cat, touring rock musician, future workplace consultant, and a firm believer in the power of bleeding-edge technologies to drive exciting and innovative careers. He is the author of the groundbreaking new book Improvising Careers:...

CloseMore

×

Saeed Amal / Chair's remarks

Saeed Amal, Research Professor In AI for Precision Medicine at Northeastern University and Visiting Professor at Harvard Medical School,
Northeastern University

Prof. Saeed Amal is a Research Professor in Bioengineering at Northeastern University and affiliated with the Roux Institute. He isa visiting professor at Harvard Medical School. Prof. Amal won the National Academy of Inventors Award of " Emerging Visionary Award in AI for...

CloseMore

×

Michelle Bridenbaker / Digital transformation within medical and scientific communications within pharma and biotech

Michelle Bridenbaker, Head of Medical Excellence & Communications,
Recordati

Michelle Bridenbaker is currently the Global Head of Medical Excellence & Communications at Recordati. Additionally, in her capacity as the Vice President Elect of Medical Information Leaders in Europe (MILE) a pan-pharmaceutical company coalition, she helps shape industry best...

CloseMore

×

Jackie Miller / The Human Heart of High-Tech Care: Reimagining the Nurse Navigator in the Age of Precision Medicine

Jackie Miller, Director Oncology Navigation,
SKCCC-Jefferson Health

Jackie Miller is the Director of Oncology Navigation at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) –Jefferson Health. SKCCC is part of an 32-hospital academic health system spanning two states and the largest in the Philadelphia region.  It is comprised of eight cancer treatment centers...

CloseMore

×

Harish Manmathan / Chair's remarks

Harish Manmathan, Sr. Director, Trial Delivery Data Strategy,
Takeda

Global lead responsible for defining and enabling the end‑to‑end data strategy for clinical development at Takeda R&D. I focus on how clinical trial data is collected, stored, managed, reported, and utilized across the full development lifecycle to drive better, faster, and more reliable...

CloseMore

×

Jin Lee / Chair's remarks

Jin Lee, Founder,
IMIDeology

Dr. Jin Lee is the Co-Founder and CEO of IMIDeology, a clinician-led autoimmune research network that bridges patients with practicing specialists in rheumatology, dermatology, and gastroenterology. She has worked across the healthcare ecosystem—from pharma and health insurance to hospital system...

CloseMore

×

Lincoln Shand / Protecting Our Cognitive Edge: The Paradox of AI Offloading vs. Skills Atrophy

Lincoln Shand, Global Technical Leader, Data Management, PD Data Science and Analytics,
Roche

Lincoln stumbled into the AI space through his love of science fiction novels. It’s no surprise, then, that by the time Watson played Jeopardy in 2011, his curiosity about AI had been fully awakened. After watching AlphaGo make its infamous move 37 in 2016, he was hooked. That passion followed him...

CloseMore

×

Angela Gill Nelms / AI-Powered Trials: Unlocking Leadership in Clinical Innovation

Angela Gill Nelms, Managing Director,
Biolocity at GT and Emory

I’m a founder, board leader, podcaster, and award-winning entrepreneur with a career spanning SaaS, medical devices, and clinical research. I build high-impact teams and organizations rooted in culture, resilience, and strategic execution—globally and sustainably. I host three shows that each...

CloseMore

×

Jin Lee / Better ways to recruit and retain patients

Jin Lee, Founder,
IMIDeology

Dr. Jin Lee is the Co-Founder and CEO of IMIDeology, a clinician-led autoimmune research network that bridges patients with practicing specialists in rheumatology, dermatology, and gastroenterology. She has worked across the healthcare ecosystem—from pharma and health insurance to hospital system...

CloseMore

×

Jackie Miller / Better ways to recruit and retain patients

Jackie Miller, Director Oncology Navigation,
SKCCC-Jefferson Health

Jackie Miller is the Director of Oncology Navigation at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) –Jefferson Health. SKCCC is part of an 32-hospital academic health system spanning two states and the largest in the Philadelphia region.  It is comprised of eight cancer treatment centers...

CloseMore

×

Saeed Amal / Digital health and AI, what does the future hold?

Saeed Amal, Research Professor In AI for Precision Medicine at Northeastern University and Visiting Professor at Harvard Medical School,
Northeastern University

Prof. Saeed Amal is a Research Professor in Bioengineering at Northeastern University and affiliated with the Roux Institute. He isa visiting professor at Harvard Medical School. Prof. Amal won the National Academy of Inventors Award of " Emerging Visionary Award in AI for...

CloseMore

×

Anu Sharma / From AI Experiments to Enterprise Impact: What Does It Really Take to Operationalize AI in Pharma

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence,
Merck

Anu Sharma is a Senior Principal Scientist and Real World Evidence platforms leader at Merck. She leads Data Sciences, Platform Strategy and Health Economic Modeling Initiatives within the MRL Biostatistics and Research Decision Sciences(BARDS) Epidemiology RWE Capabilities and Analytics working...

CloseMore

×

Sally Thompson-Iritani / Using AI in the drug development and discovery process

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs,
University of Washington

Sally Thompson-Iritani is an accomplished professional with a passion for advancing animal care, outreach, and the principles of the 3Rs (Replacement, Reduction, Refinement) in research. As the Assistant Vice Provost at the University of Washington, she leads initiatives to promote ethical and...

CloseMore

×

Nabil Adam / Using AI in the drug development and discovery process

Nabil Adam, Professor Emeritus/Co-founder,
Rutgers University

Dr. Adam’s experience spans more than 40 years across academia, government, and industry. In academia, as a Distinguished Professor of Computer and Information Systems, Professor of Medicine, my leadership roles included serving as Vice-Chancellor for Research & Collaboration and as the...

CloseMore

×

Michelle Bridenbaker / Evolution of women’s health

Michelle Bridenbaker, Head of Medical Excellence & Communications,
Recordati

Michelle Bridenbaker is currently the Global Head of Medical Excellence & Communications at Recordati. Additionally, in her capacity as the Vice President Elect of Medical Information Leaders in Europe (MILE) a pan-pharmaceutical company coalition, she helps shape industry best...

CloseMore

×

Sally Thompson-Iritani / Evolution of women’s health

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs,
University of Washington

Sally Thompson-Iritani is an accomplished professional with a passion for advancing animal care, outreach, and the principles of the 3Rs (Replacement, Reduction, Refinement) in research. As the Assistant Vice Provost at the University of Washington, she leads initiatives to promote ethical and...

CloseMore

×

Venkat Sanka / Chair's remarks

Venkat Sanka, Data Analytics & Governance Consultant,
Janssen Global Services LLC

Venkat Sanka is a seasoned data and cloud analytics leader with over 16 years of experience enabling data-driven transformation across healthcare, life sciences, and global enterprises. He currently works in data analytics and governance, leading initiatives in AI/ML, cloud platforms, and trusted...

CloseMore

×

Anu Sharma / Chair's remarks

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence,
Merck

Anu Sharma is a Senior Principal Scientist and Real World Evidence platforms leader at Merck. She leads Data Sciences, Platform Strategy and Health Economic Modeling Initiatives within the MRL Biostatistics and Research Decision Sciences(BARDS) Epidemiology RWE Capabilities and Analytics working...

CloseMore

×

Angela Gill Nelms / Chair's remarks

Angela Gill Nelms, Managing Director,
Biolocity at GT and Emory

I’m a founder, board leader, podcaster, and award-winning entrepreneur with a career spanning SaaS, medical devices, and clinical research. I build high-impact teams and organizations rooted in culture, resilience, and strategic execution—globally and sustainably. I host three shows that each...

CloseMore

×

Michael Salgaller / Beyond SPIRs calling NIH as your technology development and commercialisation partner

Michael Salgaller, Supervisory Specialist, Technology Analysis and Marketing Unit (TAMU),
National Institute of Health (NIH)

Dr. Michael Salgaller leads an alliance development unit within the NIH’s Technology Transfer Center. His unit fosters licensing and collaborative activity between buy-side stakeholders and the NIH. There, he leverages >20 years of business, scientific, and investment experience in various life...

CloseMore

×

Michael Salgaller / Beyond SPIRs calling NIH as your technology development and commercialisation partner

Michael Salgaller, Supervisory Specialist, Technology Analysis and Marketing Unit (TAMU),
National Institute of Health (NIH)

Dr. Michael Salgaller leads an alliance development unit within the NIH’s Technology Transfer Center. His unit fosters licensing and collaborative activity between buy-side stakeholders and the NIH. There, he leverages >20 years of business, scientific, and investment experience in various life...

CloseMore

×

Venkat Sanka / From High-Throughput Pipelines to FAIR Data: A Storage Strategy

Venkat Sanka, Data Analytics & Governance Consultant,
Janssen Global Services LLC

Venkat Sanka is a seasoned data and cloud analytics leader with over 16 years of experience enabling data-driven transformation across healthcare, life sciences, and global enterprises. He currently works in data analytics and governance, leading initiatives in AI/ML, cloud platforms, and trusted...

CloseMore

×

Anu Sharma / Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence,
Merck

Anu Sharma is a Senior Principal Scientist and Real World Evidence platforms leader at Merck. She leads Data Sciences, Platform Strategy and Health Economic Modeling Initiatives within the MRL Biostatistics and Research Decision Sciences(BARDS) Epidemiology RWE Capabilities and Analytics working...

CloseMore

×

Christopher Bishop / When Quantum Meets Pharma: Inside the Race to Design Drugs Atom by Atom

Christopher Bishop, Chief Reinvention Officer,
Improvising Careers

Christopher Bishop is a TEDx speaker, ex-IBMer, former NYC studio cat, touring rock musician, future workplace consultant, and a firm believer in the power of bleeding-edge technologies to drive exciting and innovative careers. He is the author of the groundbreaking new book Improvising Careers:...

CloseMore

×

Brett Engelmann / Building Bridges: Developing a Common Omics Data Platform at AbbVie

Brett Engelmann, Sr Data Scientist,
AbbVie

Brett is an experienced scientific informatics leader with extensive bioinformatics, omics data-platform, and scientific web-application development experience within a top pharmaceutical company. He is a team player who is passionate about omic applications for target ID, mechanism of action, and...

CloseMore

×

Nabil Adam / Leveraging Real-World Data and AI for the Evaluation of Clinical Trial Efficacy.

Nabil Adam, Professor Emeritus/Co-founder,
Rutgers University

Dr. Adam’s experience spans more than 40 years across academia, government, and industry. In academia, as a Distinguished Professor of Computer and Information Systems, Professor of Medicine, my leadership roles included serving as Vice-Chancellor for Research & Collaboration and as the...

CloseMore

×

Harish Manmathan / From Silos to FAIR: Driving Data Strategy in Research and Development

Harish Manmathan, Sr. Director, Trial Delivery Data Strategy,
Takeda

Global lead responsible for defining and enabling the end‑to‑end data strategy for clinical development at Takeda R&D. I focus on how clinical trial data is collected, stored, managed, reported, and utilized across the full development lifecycle to drive better, faster, and more reliable...

CloseMore

×

Venkat Sanka / Chair's remarks

Venkat Sanka, Data Analytics & Governance Consultant,
Janssen Global Services LLC

Venkat Sanka is a seasoned data and cloud analytics leader with over 16 years of experience enabling data-driven transformation across healthcare, life sciences, and global enterprises. He currently works in data analytics and governance, leading initiatives in AI/ML, cloud platforms, and trusted...

CloseMore

×

Angela Gill Nelms / Chair's remarks

Angela Gill Nelms, Managing Director,
Biolocity at GT and Emory

I’m a founder, board leader, podcaster, and award-winning entrepreneur with a career spanning SaaS, medical devices, and clinical research. I build high-impact teams and organizations rooted in culture, resilience, and strategic execution—globally and sustainably. I host three shows that each...

CloseMore

×

Sally Thompson-Iritani / How AI is used to support the three R’s in drug discovery

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs,
University of Washington

Sally Thompson-Iritani is an accomplished professional with a passion for advancing animal care, outreach, and the principles of the 3Rs (Replacement, Reduction, Refinement) in research. As the Assistant Vice Provost at the University of Washington, she leads initiatives to promote ethical and...

CloseMore

×

MaryLena Bleile / An ensemble method for robust labelling of single-cell RNA-seq data

MaryLena Bleile, Senior Statistician,
Sanofi

AI Research Scientist working at the intersection of causal inference and reinforcement learning. Currently writing a technical book on causal agents contracted to CRC Press (forthcoming 2027).Previously I led an interdisciplinary initiative in biopharma which saved up to $100k+ on clinical...

CloseMore

×

Ikhide Imumorin / Preparing the Biotech Workforce of the Future: The Role of Academic-Industry Partnerships

Ikhide Imumorin, Executive Director & Professor of Biological Sciences,,
California State University

Ikhide Imumorin is an accomplished Executive Director and Professor of Biological Sciences at California State University. He leads the California State University Biotechnology Program (CSUBIOTECH) with the mission of supporting education, research and innovation to strengthen the life science...

CloseMore